 | • レポートコード：QY20ST-09119 • 出版社/出版日：QYResearch / 2020年9月15日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、142ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥560,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥840,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,120,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、世界の非経口薬市場について種類別（LVP医薬品、SVP医薬品）、用途別（Hospitals、 Medical Centers、 Others）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・非経口薬市場の概要 ・世界の主要地域別非経口薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の非経口薬市場規模2015-2026：種類別（LVP医薬品、SVP医薬品） ・世界の非経口薬市場規模2015-2026：用途別（Hospitals、 Medical Centers、 Others） ・非経口薬の北米市場規模2015-2020 ・非経口薬のヨーロッパ市場規模2015-2020 ・非経口薬の中国市場規模2015-2020 ・非経口薬の日本市場規模2015-2020 ・非経口薬の東南アジア市場規模2015-2020 ・非経口薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・非経口薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・非経口薬の市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Parenteral Drugs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Parenteral Drugs market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Parenteral Drug (LVP, SVP) is defined as one intended for injection through the skin or other external boundary tissue, rather than through the alimentary canal, so that active substances they contain are administered, using gravity or force, directly into a blood vessel, organ, tissue, or lesion. They are infused when administered intravenously (IV), or injected when administered intramuscularly (IM), or subcutaneously into the human body. A large volume parenteral (LVP) is a unit dose container of greater than 100ml that is terminally sterilized by heat. Small volume parenteral (SVP) is a “catch-all” for all non-LVP parenterals products except biologicals.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Parenteral Drugs market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Parenteral Drugs industry.
Based on our recent survey, we have several different scenarios about the Parenteral Drugs YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Parenteral Drugs will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Parenteral Drugs market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Parenteral Drugs market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Parenteral Drugs market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Parenteral Drugs market. The report also includes nautical information, where it shows Parenteral Drugs market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Parenteral Drugs market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Parenteral Drugs market.
Parenteral drugs, whether a small-molecule or biologic-based drug substance, has increased their share of the overall drug market although solid-dosage products still prevail.
Geographical Analysis:
Based on region, the global Parenteral Drugs market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Parenteral Drugs market are
Ostuka Pharmaceutical
Teva Pharmaceutical Industries
Kelun Pharma
Cook Pharmica
Patheon
BAG Healthcare
Beximco Pharma
Baxter Healthcare Corporation
B. Braun
Fresenius
Albert David
BML Parenteral Drugs
Pfizer (Hospira)
Pisa
Ozon Pharmaceuticals Ltd
Aspen Holdings
PSI Ltd
Wintac Limited
AXA Parenterals Ltd
Acebright
Southwest Pharmaceutical
Abbott
Segment by Type
LVP Drug
SVP Drug
Segment by Application
Hospitals
Medical Centers
Others
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Parenteral Drugs market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Parenteral Drugs market.
• The market share of the global Parenteral Drugs market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Parenteral Drugs market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Parenteral Drugs market.
1 Parenteral Drugs Market Overview
1.1 Parenteral Drugs Product Scope
1.2 Parenteral Drugs Segment by Type
1.2.1 Global Parenteral Drugs Sales by Type (2020-2026)
1.2.2 LVP Drug
1.2.3 SVP Drug
1.3 Parenteral Drugs Segment by Application
1.3.1 Global Parenteral Drugs Sales Comparison by Application (2020-2026)
1.3.2 Hospitals
1.3.3 Medical Centers
1.3.4 Others
1.4 Parenteral Drugs Market Estimates and Forecasts (2015-2026)
1.4.1 Global Parenteral Drugs Sales Growth Rate (2015-2026)
1.4.2 Global Parenteral Drugs Revenue and Growth Rate (2015-2026)
1.4.3 Global Parenteral Drugs Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Parenteral Drugs Industry Impact
1.5.1 How the Covid-19 is Affecting the Parenteral Drugs Industry
1.5.1.1 Parenteral Drugs Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Parenteral Drugs Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Parenteral Drugs Players to Combat Covid-19 Impact
2 Parenteral Drugs Estimate and Forecast by Region
2.1 Global Parenteral Drugs Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Parenteral Drugs Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Parenteral Drugs Sales Market Share by Region (2015-2020)
2.2.2 Global Parenteral Drugs Revenue Market Share by Region (2015-2020)
2.3 Global Parenteral Drugs Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Parenteral Drugs Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Parenteral Drugs Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Parenteral Drugs Estimates and Projections (2015-2026)
2.4.2 Europe Parenteral Drugs Estimates and Projections (2015-2026)
2.4.3 China Parenteral Drugs Estimates and Projections (2015-2026)
2.4.4 Japan Parenteral Drugs Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Parenteral Drugs Estimates and Projections (2015-2026)
2.4.6 India Parenteral Drugs Estimates and Projections (2015-2026)
3 Global Parenteral Drugs Competition Landscape by Players
3.1 Global Top Parenteral Drugs Players by Sales (2015-2020)
3.2 Global Top Parenteral Drugs Players by Revenue (2015-2020)
3.3 Global Parenteral Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parenteral Drugs as of 2019)
3.4 Global Parenteral Drugs Average Price by Company (2015-2020)
3.5 Manufacturers Parenteral Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Parenteral Drugs Players (Opinion Leaders)
4 Global Parenteral Drugs Market Size by Type
4.1 Global Parenteral Drugs Historic Market Review by Type (2015-2020)
4.1.1 Global Parenteral Drugs Sales Market Share by Type (2015-2020)
4.1.2 Global Parenteral Drugs Revenue Market Share by Type (2015-2020)
4.1.3 Global Parenteral Drugs Price by Type (2014-2020)
4.2 Global Parenteral Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Parenteral Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Parenteral Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Global Parenteral Drugs Price Forecast by Type (2021-2026)
5 Global Parenteral Drugs Market Size by Application
5.1 Global Parenteral Drugs Historic Market Review by Application (2015-2020)
5.1.1 Global Parenteral Drugs Sales Market Share by Application (2015-2020)
5.1.2 Global Parenteral Drugs Revenue Market Share by Application (2015-2020)
5.1.3 Global Parenteral Drugs Price by Application (2015-2020)
5.2 Global Parenteral Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Parenteral Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Parenteral Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Parenteral Drugs Price Forecast by Application (2021-2026)
3 North America Parenteral Drugs Market Facts & Figures
3.2 North America Parenteral Drugs Sales Market Share by Company (2015-2020)
3.3 North America Parenteral Drugs Sales Market Share by Type (2015-2020)
3.4 North America Parenteral Drugs Sales Market Share by Application (2015-2020)
4 Europe Parenteral Drugs Market Facts & Figures
4.2 Europe Parenteral Drugs Sales Market Share by Company (2015-2020)
4.3 Europe Parenteral Drugs Sales Market Share by Type (2015-2020)
4.4 Europe Parenteral Drugs Sales Market Share by Application (2015-2020)
5 China Parenteral Drugs Market Facts & Figures
5.2 China Parenteral Drugs Sales Market Share by Company (2015-2020)
5.3 China Parenteral Drugs Sales Market Share by Type (2015-2020)
5.4 China Parenteral Drugs Sales Market Share by Application (2015-2020)
6 Japan Parenteral Drugs Market Facts & Figures
6.2 Japan Parenteral Drugs Sales Market Share by Company (2015-2020)
6.3 Japan Parenteral Drugs Sales Market Share by Type (2015-2020)
6.4 Japan Parenteral Drugs Sales Market Share by Application (2015-2020)
7 Southeast Asia Parenteral Drugs Market Facts & Figures
7.2 Southeast Asia Parenteral Drugs Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Parenteral Drugs Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Parenteral Drugs Sales Market Share by Application (2015-2020)
8 India Parenteral Drugs Market Facts & Figures
8.2 India Parenteral Drugs Sales Market Share by Company (2015-2020)
8.3 India Parenteral Drugs Sales Market Share by Type (2015-2020)
8.4 India Parenteral Drugs Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Parenteral Drugs Business
12.1 Ostuka Pharmaceutical
12.1.1 Ostuka Pharmaceutical Parenteral Drugs Corporation Information
12.1.2 Ostuka Pharmaceutical Parenteral Drugs Business Overview and Total Revenue
12.1.3 Ostuka Pharmaceutical Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Ostuka Pharmaceutical Parenteral Drugs Products Offered
12.1.5 Ostuka Pharmaceutical Recent Development
12.2 Teva Pharmaceutical Industries
12.2.1 Teva Pharmaceutical Industries Parenteral Drugs Corporation Information
12.2.2 Teva Pharmaceutical Industries Parenteral Drugs Business Overview and Total Revenue
12.2.3 Teva Pharmaceutical Industries Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Teva Pharmaceutical Industries Parenteral Drugs Products Offered
12.2.5 Teva Pharmaceutical Industries Recent Development
12.3 Kelun Pharma
12.3.1 Kelun Pharma Parenteral Drugs Corporation Information
12.3.2 Kelun Pharma Parenteral Drugs Business Overview and Total Revenue
12.3.3 Kelun Pharma Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Kelun Pharma Parenteral Drugs Products Offered
12.3.5 Kelun Pharma Recent Development
12.4 Cook Pharmica
12.4.1 Cook Pharmica Parenteral Drugs Corporation Information
12.4.2 Cook Pharmica Parenteral Drugs Business Overview and Total Revenue
12.4.3 Cook Pharmica Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Cook Pharmica Parenteral Drugs Products Offered
12.4.5 Cook Pharmica Recent Development
12.5 Patheon
12.5.1 Patheon Parenteral Drugs Corporation Information
12.5.2 Patheon Parenteral Drugs Business Overview and Total Revenue
12.5.3 Patheon Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Patheon Parenteral Drugs Products Offered
12.5.5 Patheon Recent Development
12.6 BAG Healthcare
12.6.1 BAG Healthcare Parenteral Drugs Corporation Information
12.6.2 BAG Healthcare Parenteral Drugs Business Overview and Total Revenue
12.6.3 BAG Healthcare Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.6.4 BAG Healthcare Parenteral Drugs Products Offered
12.6.5 BAG Healthcare Recent Development
12.7 Beximco Pharma
12.7.1 Beximco Pharma Parenteral Drugs Corporation Information
12.7.2 Beximco Pharma Parenteral Drugs Business Overview and Total Revenue
12.7.3 Beximco Pharma Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Beximco Pharma Parenteral Drugs Products Offered
12.7.5 Beximco Pharma Recent Development
12.8 Baxter Healthcare Corporation
12.8.1 Baxter Healthcare Corporation Parenteral Drugs Corporation Information
12.8.2 Baxter Healthcare Corporation Parenteral Drugs Business Overview and Total Revenue
12.8.3 Baxter Healthcare Corporation Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Baxter Healthcare Corporation Parenteral Drugs Products Offered
12.8.5 Baxter Healthcare Corporation Recent Development
12.9 B. Braun
12.9.1 B. Braun Parenteral Drugs Corporation Information
12.9.2 B. Braun Parenteral Drugs Business Overview and Total Revenue
12.9.3 B. Braun Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.9.4 B. Braun Parenteral Drugs Products Offered
12.9.5 B. Braun Recent Development
12.10 Fresenius
12.10.1 Fresenius Parenteral Drugs Corporation Information
12.10.2 Fresenius Parenteral Drugs Business Overview and Total Revenue
12.10.3 Fresenius Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Fresenius Parenteral Drugs Products Offered
12.10.5 Fresenius Recent Development
12.11 Albert David
12.11.1 Albert David Parenteral Drugs Corporation Information
12.11.2 Albert David Parenteral Drugs Business Overview and Total Revenue
12.11.3 Albert David Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Albert David Parenteral Drugs Products Offered
12.11.5 Albert David Recent Development
12.12 BML Parenteral Drugs
12.12.1 BML Parenteral Drugs Parenteral Drugs Corporation Information
12.12.2 BML Parenteral Drugs Parenteral Drugs Business Overview and Total Revenue
12.12.3 BML Parenteral Drugs Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.12.4 BML Parenteral Drugs Parenteral Drugs Products Offered
12.12.5 BML Parenteral Drugs Recent Development
12.13 Pfizer (Hospira)
12.13.1 Pfizer (Hospira) Parenteral Drugs Corporation Information
12.13.2 Pfizer (Hospira) Parenteral Drugs Business Overview and Total Revenue
12.13.3 Pfizer (Hospira) Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Pfizer (Hospira) Parenteral Drugs Products Offered
12.13.5 Pfizer (Hospira) Recent Development
12.14 Pisa
12.14.1 Pisa Parenteral Drugs Corporation Information
12.14.2 Pisa Parenteral Drugs Business Overview and Total Revenue
12.14.3 Pisa Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Pisa Parenteral Drugs Products Offered
12.14.5 Pisa Recent Development
12.15 Ozon Pharmaceuticals Ltd
12.15.1 Ozon Pharmaceuticals Ltd Parenteral Drugs Corporation Information
12.15.2 Ozon Pharmaceuticals Ltd Parenteral Drugs Business Overview and Total Revenue
12.15.3 Ozon Pharmaceuticals Ltd Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Ozon Pharmaceuticals Ltd Parenteral Drugs Products Offered
12.15.5 Ozon Pharmaceuticals Ltd Recent Development
12.16 Aspen Holdings
12.16.1 Aspen Holdings Parenteral Drugs Corporation Information
12.16.2 Aspen Holdings Parenteral Drugs Business Overview and Total Revenue
12.16.3 Aspen Holdings Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Aspen Holdings Parenteral Drugs Products Offered
12.16.5 Aspen Holdings Recent Development
12.17 PSI Ltd
12.17.1 PSI Ltd Parenteral Drugs Corporation Information
12.17.2 PSI Ltd Parenteral Drugs Business Overview and Total Revenue
12.17.3 PSI Ltd Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.17.4 PSI Ltd Parenteral Drugs Products Offered
12.17.5 PSI Ltd Recent Development
12.18 Wintac Limited
12.18.1 Wintac Limited Parenteral Drugs Corporation Information
12.18.2 Wintac Limited Parenteral Drugs Business Overview and Total Revenue
12.18.3 Wintac Limited Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.18.4 Wintac Limited Parenteral Drugs Products Offered
12.18.5 Wintac Limited Recent Development
12.19 AXA Parenterals Ltd
12.19.1 AXA Parenterals Ltd Parenteral Drugs Corporation Information
12.19.2 AXA Parenterals Ltd Parenteral Drugs Business Overview and Total Revenue
12.19.3 AXA Parenterals Ltd Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.19.4 AXA Parenterals Ltd Parenteral Drugs Products Offered
12.19.5 AXA Parenterals Ltd Recent Development
12.20 Acebright
12.20.1 Acebright Parenteral Drugs Corporation Information
12.20.2 Acebright Parenteral Drugs Business Overview and Total Revenue
12.20.3 Acebright Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.20.4 Acebright Parenteral Drugs Products Offered
12.20.5 Acebright Recent Development
12.21 Southwest Pharmaceutical
12.21.1 Southwest Pharmaceutical Parenteral Drugs Corporation Information
12.21.2 Southwest Pharmaceutical Parenteral Drugs Business Overview and Total Revenue
12.21.3 Southwest Pharmaceutical Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.21.4 Southwest Pharmaceutical Parenteral Drugs Products Offered
12.21.5 Southwest Pharmaceutical Recent Development
12.22 Abbott
12.22.1 Abbott Parenteral Drugs Corporation Information
12.22.2 Abbott Parenteral Drugs Business Overview and Total Revenue
12.22.3 Abbott Parenteral Drugs Sales, Revenue and Gross Margin (2015-2020)
12.22.4 Abbott Parenteral Drugs Products Offered
12.22.5 Abbott Recent Development
13 Parenteral Drugs Manufacturing Cost Analysis
13.1 Parenteral Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Parenteral Drugs
13.4 Parenteral Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Parenteral Drugs Distributors List
14.3 Parenteral Drugs Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Parenteral Drugs Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Parenteral Drugs Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Parenteral Drugs Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Parenteral Drugs Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Parenteral Drugs Players to Combat Covid-19 Impact
Table 8. Global Market Parenteral Drugs Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Parenteral Drugs Sales (K Units) by Region (2015-2020)
Table 10. Global Parenteral Drugs Sales Market Share by Region (2015-2020)
Table 11. Global Parenteral Drugs Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Parenteral Drugs Revenue Share by Region (2015-2020)
Table 13. Global Parenteral Drugs Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global Parenteral Drugs Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Parenteral Drugs Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Parenteral Drugs Revenue Share Forecast by Region (2021-2026)
Table 17. Global Parenteral Drugs (K Units) of Key Companies (2015-2020)
Table 18. Global Parenteral Drugs Sales Share by Company (2015-2020)
Table 19. Global Parenteral Drugs Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Parenteral Drugs Revenue Share by Company (2015-2020)
Table 21. Global Parenteral Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parenteral Drugs as of 2019)
Table 22. Global Parenteral Drugs Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Parenteral Drugs Manufacturing Sites and Area Served
Table 24. Manufacturers Parenteral Drugs Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Parenteral Drugs Players
Table 27. Global Parenteral Drugs Sales (K Units) by Type (2015-2020)
Table 28. Global Parenteral Drugs Sales Share by Type (2015-2020)
Table 29. Global Parenteral Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Parenteral Drugs Price (K Units) by Type (2015-2020)
Table 31. Global Parenteral Drugs Sales Share by Type (2021-2026)
Table 32. Global Parenteral Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Parenteral Drugs Revenue Share by Type (2021-2026)
Table 34. Global Parenteral Drugs Price (K Units) by Type (2021-2026)
Table 35. Global Parenteral Drugs Sales (K Units) by Application (2015-2020)
Table 36. Global Parenteral Drugs Sales Share by Application (2015-2020)
Table 37. Global Parenteral Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Parenteral Drugs Price (K Units) by Application (2015-2020)
Table 39. Global Parenteral Drugs Sales (K Units) by Application (2021-2026)
Table 40. Global Parenteral Drugs Sales Share by Application (2021-2026)
Table 41. Global Parenteral Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Parenteral Drugs Revenue Share by Application (2021-2026)
Table 43. Global Parenteral Drugs Price (K Units) by Application (2021-2026)
Table 44. United States Parenteral Drugs Sales (K Units) by Company (2015-2020)
Table 45. United States Parenteral Drugs Sales Market Share by Company (2015-2020)
Table 46. United States Parenteral Drugs Sales (K Units) by Type (2015-2020)
Table 47. United States Parenteral Drugs Sales Market Share by Type (2015-2020)
Table 48. United States Parenteral Drugs Sales (K Units) by Application (2015-2020)
Table 49. United States Parenteral Drugs Sales Market Share by Application (2015-2020)
Table 50. Europe Parenteral Drugs Sales (K Units) by Company (2015-2020)
Table 51. Europe Parenteral Drugs Sales Market Share by Company (2015-2020)
Table 52. Europe Parenteral Drugs Sales (K Units) by Type (2015-2020)
Table 53. Europe Parenteral Drugs Sales Market Share by Type (2015-2020)
Table 54. Europe Parenteral Drugs Sales (K Units) by Application (2015-2020)
Table 55. Europe Parenteral Drugs Sales Market Share by Type (2015-2020)
Table 56. China Parenteral Drugs Sales (K Units) by Company (2015-2020)
Table 57. China Parenteral Drugs Sales Market Share by Company (2015-2020)
Table 58. China Parenteral Drugs Sales (K Units) by Type (2015-2020)
Table 59. China Parenteral Drugs Sales Market Share by Type (2015-2020)
Table 60. China Parenteral Drugs Sales (K Units) by Application (2015-2020)
Table 61. China Parenteral Drugs Sales Market Share by Application (2015-2020)
Table 62. Japan Parenteral Drugs Sales (K Units) by Company (2015-2020)
Table 63. Japan Parenteral Drugs Sales Market Share by Company (2015-2020)
Table 64. Japan Parenteral Drugs Sales (K Units) by Type (2015-2020)
Table 65. Japan Parenteral Drugs Sales Market Share by Type (2015-2020)
Table 66. Japan Parenteral Drugs Sales (K Units) by Application (2015-2020)
Table 67. Japan Parenteral Drugs Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Parenteral Drugs Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia Parenteral Drugs Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Parenteral Drugs Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia Parenteral Drugs Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Parenteral Drugs Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia Parenteral Drugs Sales Market Share by Application (2015-2020)
Table 74. India Parenteral Drugs Sales (K Units) by Company (2015-2020)
Table 75. India Parenteral Drugs Sales Market Share by Company (2015-2020)
Table 76. India Parenteral Drugs Sales (K Units) by Type (2015-2020)
Table 77. India Parenteral Drugs Sales Market Share by Type (2015-2020)
Table 78. India Parenteral Drugs Sales (K Units) by Application (2015-2020)
Table 79. India Parenteral Drugs Sales Market Share by Application (2015-2020)
Table 80. Ostuka Pharmaceutical Corporation Information
Table 81. Ostuka Pharmaceutical Description and Business Overview
Table 82. Ostuka Pharmaceutical Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Ostuka Pharmaceutical Parenteral Drugs Product
Table 84. Ostuka Pharmaceutical Recent Development
Table 85. Teva Pharmaceutical Industries Corporation Information
Table 86. Teva Pharmaceutical Industries Description and Business Overview
Table 87. Teva Pharmaceutical Industries Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Teva Pharmaceutical Industries Parenteral Drugs Product
Table 89. Teva Pharmaceutical Industries Recent Development
Table 90. Kelun Pharma Corporation Information
Table 91. Kelun Pharma Description and Business Overview
Table 92. Kelun Pharma Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Kelun Pharma Parenteral Drugs Product
Table 94. Kelun Pharma Recent Development
Table 95. Cook Pharmica Corporation Information
Table 96. Cook Pharmica Description and Business Overview
Table 97. Cook Pharmica Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Cook Pharmica Parenteral Drugs Product
Table 99. Cook Pharmica Recent Development
Table 100. Patheon Corporation Information
Table 101. Patheon Description and Business Overview
Table 102. Patheon Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Patheon Parenteral Drugs Product
Table 104. Patheon Recent Development
Table 105. BAG Healthcare Corporation Information
Table 106. BAG Healthcare Description and Business Overview
Table 107. BAG Healthcare Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. BAG Healthcare Parenteral Drugs Product
Table 109. BAG Healthcare Recent Development
Table 110. Beximco Pharma Corporation Information
Table 111. Beximco Pharma Description and Business Overview
Table 112. Beximco Pharma Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Beximco Pharma Parenteral Drugs Product
Table 114. Beximco Pharma Recent Development
Table 115. Baxter Healthcare Corporation Corporation Information
Table 116. Baxter Healthcare Corporation Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Baxter Healthcare Corporation Description and Business Overview
Table 118. Baxter Healthcare Corporation Parenteral Drugs Product
Table 119. Baxter Healthcare Corporation Recent Development
Table 120. B. Braun Corporation Information
Table 121. B. Braun Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. B. Braun Description and Business Overview
Table 123. B. Braun Parenteral Drugs Product
Table 124. B. Braun Recent Development
Table 125. Fresenius Corporation Information
Table 126. Fresenius Description and Business Overview
Table 127. Fresenius Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Fresenius Parenteral Drugs Product
Table 129. Fresenius Recent Development
Table 130. Albert David Corporation Information
Table 131. Albert David Description and Business Overview
Table 132. Albert David Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Albert David Parenteral Drugs Product
Table 134. Albert David Recent Development
Table 135. BML Parenteral Drugs Corporation Information
Table 136. BML Parenteral Drugs Description and Business Overview
Table 137. BML Parenteral Drugs Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. BML Parenteral Drugs Parenteral Drugs Product
Table 139. BML Parenteral Drugs Recent Development
Table 140. Pfizer (Hospira) Corporation Information
Table 141. Pfizer (Hospira) Description and Business Overview
Table 142. Pfizer (Hospira) Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 143. Pfizer (Hospira) Parenteral Drugs Product
Table 144. Pfizer (Hospira) Recent Development
Table 145. Pisa Corporation Information
Table 146. Pisa Description and Business Overview
Table 147. Pisa Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 148. Pisa Parenteral Drugs Product
Table 149. Pisa Recent Development
Table 150. Ozon Pharmaceuticals Ltd Corporation Information
Table 151. Ozon Pharmaceuticals Ltd Description and Business Overview
Table 152. Ozon Pharmaceuticals Ltd Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 153. Ozon Pharmaceuticals Ltd Parenteral Drugs Product
Table 154. Ozon Pharmaceuticals Ltd Recent Development
Table 155. Aspen Holdings Corporation Information
Table 156. Aspen Holdings Description and Business Overview
Table 157. Aspen Holdings Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 158. Aspen Holdings Parenteral Drugs Product
Table 159. Aspen Holdings Recent Development
Table 160. PSI Ltd Corporation Information
Table 161. PSI Ltd Description and Business Overview
Table 162. PSI Ltd Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 163. PSI Ltd Parenteral Drugs Product
Table 164. PSI Ltd Recent Development
Table 165. Wintac Limited Corporation Information
Table 166. Wintac Limited Description and Business Overview
Table 167. Wintac Limited Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 168. Wintac Limited Parenteral Drugs Product
Table 169. Wintac Limited Recent Development
Table 170. AXA Parenterals Ltd Corporation Information
Table 171. AXA Parenterals Ltd Description and Business Overview
Table 172. AXA Parenterals Ltd Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 173. AXA Parenterals Ltd Parenteral Drugs Product
Table 174. AXA Parenterals Ltd Recent Development
Table 175. Acebright Corporation Information
Table 176. Acebright Description and Business Overview
Table 177. Acebright Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 178. Acebright Parenteral Drugs Product
Table 179. Acebright Recent Development
Table 180. Southwest Pharmaceutical Corporation Information
Table 181. Southwest Pharmaceutical Description and Business Overview
Table 182. Southwest Pharmaceutical Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 183. Southwest Pharmaceutical Parenteral Drugs Product
Table 184. Southwest Pharmaceutical Recent Development
Table . Abbott Corporation Information
Table . Abbott Description and Business Overview
Table . Abbott Parenteral Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . Abbott Parenteral Drugs Product
Table . Abbott Recent Development
Table 190. Production Base and Market Concentration Rate of Raw Material
Table 191. Key Suppliers of Raw Materials
Table 192. Parenteral Drugs Distributors List
Table 193. Parenteral Drugs Customers List
Table 194. Market Key Trends
Table 195. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 196. Key Challenges
Table 197. Research Programs/Design for This Report
Table 198. Key Data Information from Secondary Sources
Table 199. Key Data Information from Primary Sources
List of Figures
Figure 1. Parenteral Drugs Product Picture
Figure 2. Global Parenteral Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Parenteral Drugs Market Share by Application in 2020 & 2026
Figure 6. Hospitals Examples
Figure 7. Medical Centers Examples
Figure 8. Others Examples
Figure 9. Global Parenteral Drugs Sales (K Units) Growth Rate (2015-2026)
Figure 10. Global Parenteral Drugs Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Parenteral Drugs Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 12. Global Parenteral Drugs Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Parenteral Drugs Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Parenteral Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Parenteral Drugs Sales (K Units) Growth Rate (2015-2026)
Figure 16. Europe Parenteral Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Parenteral Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Parenteral Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Parenteral Drugs Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Parenteral Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Parenteral Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Parenteral Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Parenteral Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Parenteral Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Parenteral Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Parenteral Drugs Players Market Share by Revenue in Parenteral Drugs 2015 & 2019
Figure 27. Parenteral Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Parenteral Drugs Revenue Share by Type (2015-2020)
Figure 29. Global Parenteral Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Parenteral Drugs Revenue Share by Application (2015-2020)
Figure 31. Global Parenteral Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Parenteral Drugs Sales Market Share by Type in 2019
Figure 33. United States Parenteral Drugs Sales Market Share by Type in 2019
Figure 34. Europe Parenteral Drugs Sales Market Share by Company in 2019
Figure 35. Europe Parenteral Drugs Sales Market Share by Type in 2019
Figure 36. Europe Parenteral Drugs Sales Market Share by Application in 2019
Figure 37. China Parenteral Drugs Sales Market Share by Company in 2019
Figure 38. China Parenteral Drugs Sales Market Share by Type in 2019
Figure 39. China Parenteral Drugs Sales Market Share by Application in 2019
Figure 40. Japan Parenteral Drugs Sales Market Share by Company in 2019
Figure 41. Japan Parenteral Drugs Sales Market Share by Type in 2019
Figure 42. Japan Parenteral Drugs Sales Market Share by Application in 2019
Figure 43. Southeast Asia Parenteral Drugs Sales Market Share by Company in 2019
Figure 44. Southeast Asia Parenteral Drugs Sales Market Share by Type in 2019
Figure 45. Southeast Asia Parenteral Drugs Sales Market Share by Application in 2019
Figure 46. India Parenteral Drugs Sales Market Share by Company in 2019
Figure 47. India Parenteral Drugs Sales Market Share by Type in 2019
Figure 48. India Parenteral Drugs Sales Market Share by Application in 2019
Figure 49. Ostuka Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Teva Pharmaceutical Industries Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Kelun Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Cook Pharmica Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Patheon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. BAG Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Beximco Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Baxter Healthcare Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. B. Braun Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Fresenius Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Albert David Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. BML Parenteral Drugs Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Pfizer (Hospira) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Pisa Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Ozon Pharmaceuticals Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Aspen Holdings Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. PSI Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 66. Wintac Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 67. AXA Parenterals Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 68. Acebright Total Revenue (US$ Million): 2019 Compared with 2018
Figure 69. Southwest Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 70. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 71. Key Raw Materials Price Trend
Figure 72. Manufacturing Cost Structure of Parenteral Drugs
Figure 73. Manufacturing Process Analysis of Parenteral Drugs
Figure 74. Parenteral Drugs Industrial Chain Analysis
Figure 75. Channels of Distribution
Figure 76. Distributors Profiles
Figure 77. Porter's Five Forces Analysis
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed
非侵襲的非経口スクリーニング器具の世界市場レポート2020 A recently published report by QY Research titled Global Non-invasive Parenteral Screening Instruments Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also stat…- アディソン病薬の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Addison’s Disease Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…
- 甲状腺機能低下症薬の世界市場レポート2020 A recently published report by QY Research titled Global Hypothyroidism Drugs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accura…
- 閉経薬の世界市場レポート2020 A recently published report by QY Research titled Global Menopause Drugs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate da…
- 抗コリン性乗り物酔い薬の世界市場レポート2020 A recently published report by QY Research titled Global Anticholinergic Travel Sickness Drugs Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statisticall…